These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23274649)

  • 1. Ischemic stroke and traumatic brain injury: the role of the kallikrein-kinin system.
    Albert-Weißenberger C; Sirén AL; Kleinschnitz C
    Prog Neurobiol; 2013; 101-102():65-82. PubMed ID: 23274649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the kallikrein-kinin system in traumatic brain injury.
    Albert-Weissenberger C; Mencl S; Hopp S; Kleinschnitz C; Sirén AL
    Front Cell Neurosci; 2014; 8():345. PubMed ID: 25404891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.
    Chao J; Bledsoe G; Yin H; Chao L
    Biol Chem; 2006 Jun; 387(6):665-75. PubMed ID: 16800727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 3: Inhibition of the kallikrein-kinin system in traumatic brain swelling.
    Unterberg A; Dautermann C; Baethmann A; Müller-Esterl W
    J Neurosurg; 1986 Feb; 64(2):269-76. PubMed ID: 2418176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.
    Gröger M; Lebesgue D; Pruneau D; Relton J; Kim SW; Nussberger J; Plesnila N
    J Cereb Blood Flow Metab; 2005 Aug; 25(8):978-89. PubMed ID: 15815587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotection and kallikrein-kinin system in acute myocardial ischaemia in mice.
    Messadi-Laribi E; Griol-Charhbili V; Gaies E; Vincent MP; Heudes D; Meneton P; Alhenc-Gelas F; Richer C
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):489-93. PubMed ID: 18307747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kallikrein/kinin system and kinin antagonists in trauma.
    Rodell TC
    Immunopharmacology; 1996 Jun; 33(1-3):279-83. PubMed ID: 8856162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallikrein-kinin in stroke, cardiovascular and renal disease.
    Chao J; Chao L
    Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration.
    Westermann D; Schultheiss HP; Tschöpe C
    Int Immunopharmacol; 2008 Feb; 8(2):148-54. PubMed ID: 18182218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikrein-kinin system in hepatic experimental models.
    Kouyoumdjian M; Nagaoka MR; Borges DR
    Peptides; 2005 Aug; 26(8):1301-7. PubMed ID: 16042971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically altered animal models in the kallikrein-kinin system.
    Pesquero JB; Bader M
    Biol Chem; 2006 Feb; 387(2):119-26. PubMed ID: 16497143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallikrein-kinin system: a surgical perspective in post-aprotinin era.
    Saxena P; Thompson P; d'Udekem Y; Konstantinov IE
    J Surg Res; 2011 May; 167(1):70-7. PubMed ID: 20605589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke.
    Turner R; Vink R
    Drug News Perspect; 2007 May; 20(4):221-6. PubMed ID: 17637934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviation of secondary brain injury, posttraumatic inflammation, and brain edema formation by inhibition of factor XIIa.
    Hopp S; Nolte MW; Stetter C; Kleinschnitz C; Sirén AL; Albert-Weissenberger C
    J Neuroinflammation; 2017 Feb; 14(1):39. PubMed ID: 28219400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participation of kallikrein-kinin system in different pathologies.
    Costa-Neto CM; Dillenburg-Pilla P; Heinrich TA; Parreiras-e-Silva LT; Pereira MG; Reis RI; Souza PP
    Int Immunopharmacol; 2008 Feb; 8(2):135-42. PubMed ID: 18182216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system.
    Wisniewski P; Gangnus T; Burckhardt BB
    J Transl Med; 2024 Apr; 22(1):388. PubMed ID: 38671481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.
    Nokkari A; Abou-El-Hassan H; Mechref Y; Mondello S; Kindy MS; Jaffa AA; Kobeissy F
    Prog Neurobiol; 2018; 165-167():26-50. PubMed ID: 29355711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood kallikrein-kinin system in ischemic stroke patients].
    Burd GS; Chirkova LD; Sheliakina LA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(12):1804-8. PubMed ID: 6971549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of neurotropin on brain edema induced by permanent focal cerebral ischemia in rats and collateral ventricular injection of carrageenan in mice].
    Qu Z; Wei G; Zhang L; Wu J; Zhang J
    Yao Xue Xue Bao; 1998; 33(2):98-101. PubMed ID: 11938957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kallikrein-kinin system along the different stages of gestation: experimental and clinical findings.
    Valdés G; Corthorn J; Figueroa CD
    Biol Res; 1998; 31(3):235-41. PubMed ID: 9830511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.